Voloridge Investment Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $773K | Buy |
+26,144
| New | +$773K | ﹤0.01% | 1047 |
|
|
2024
Q4 | – | Sell |
-15,131
| Closed | -$585K | – | 1210 |
|
|
2024
Q3 | $585K | Buy |
+15,131
| New | +$585K | ﹤0.01% | 1070 |
|
|
2023
Q4 | – | Sell |
-29,922
| Closed | -$669K | – | 1214 |
|
|
2023
Q3 | $669K | Sell |
29,922
-76,041
| -72% | -$1.7M | ﹤0.01% | 1166 |
|
|
2023
Q2 | $2.28M | Sell |
105,963
-18,178
| -15% | -$391K | 0.01% | 946 |
|
|
2023
Q1 | $2.98M | Buy |
+124,141
| New | +$2.98M | 0.01% | 847 |
|
|
2020
Q4 | – | Sell |
-37,244
| Closed | -$775K | – | 1353 |
|
|
2020
Q3 | $775K | Buy |
+37,244
| New | +$775K | 0.01% | 1008 |
|
|
2020
Q2 | – | Sell |
-18,773
| Closed | -$307K | – | 1291 |
|
|
2020
Q1 | $307K | Buy |
18,773
+4,597
| +32% | +$75.2K | 0.01% | 861 |
|
|
2019
Q4 | $292K | Buy |
+14,176
| New | +$292K | 0.01% | 940 |
|
|
2019
Q2 | – | Sell |
-21,212
| Closed | -$321K | – | 798 |
|
|
2019
Q1 | $321K | Buy |
+21,212
| New | +$321K | 0.01% | 788 |
|